Prognostic value of CD25/CD123 pattern of expression in acute myeloid leukemia patients with normal cytogenetic

This study was designed to assess the significance of interleukin-2 receptor (CD25) and inteleukin-3 receptor (CD123) expression in cytogenetically normal acute myeloid leukemia (CN-AML) patients. The current study includes 80 CN-AML (≤ 60 years) before the start of therapy. Blast cells expression f...

Full description

Bibliographic Details
Main Authors: Salah Aref, Emaad Azmy, Lamiaa Ibrahim, Mohamed Sabry, Mohamed El Agdar
Format: Article
Language:English
Published: Elsevier 2020-01-01
Series:Leukemia Research Reports
Subjects:
AML
Online Access:http://www.sciencedirect.com/science/article/pii/S2213048920300091